Incidence and outcomes of critical illness-related corticosteroid insufficiency in trauma patients

American Surgeon

Volumn 77, Issue 5, 2011, Pages 579-585

  Walker, Mark L ^a   Owen, Phillip S ^a,b   Sampson, Candace ^c   Marshall, Janene ^d   Pounds, Teresa ^b   Henderson, Vernon J ^a  

^a ATLANTA MEDICAL CENTER   (United States)

^b MERCER UNIVERSITY   (United States)

^c HAMPTON UNIVERSITY   (United States)

^d CHICAGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; GLUCOSE; HYDROCORTISONE;

ADRENAL DISEASE; ADRENAL INJURY; ADULT; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICAL ILLNESS RELATED CORTICOSTEROID INSUFFICIENCY; DISEASE SEVERITY; DRUG EFFICACY; ENDOCRINE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INJURY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENETRATING TRAUMA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SPINAL CORD INJURY; SURVIVAL RATE; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; ADULT; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; MULTIPLE TRAUMA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SPINAL CORD INJURIES; SURVIVAL RATE; TRAUMA CENTERS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 79958179372     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49.
2. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-93.
3. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006;174:1319-26. (Pubitemid 44913033)
4. Lipiner-Friedman D, Sprung CL, Laterre PF, et al. Adrenal function in sepsis: the retrospective CORTICUS cohort study. Crit Care Med 2007;35:1012-8. (Pubitemid 46598949)
5. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009;301:2362-75.
6. Guillamondegui OD, Gunter OL, Patel S, et al. Acute adrenal insufficiency may affect outcome in the trauma patient. Am Surg 2009;75:287-90.
7. Fann SA, Kosciusko RD, Yost MJ, et al. The use of prognostic indicators in the development of a statistical model predictive for adrenal insufficiency in trauma patients. Am Surg 2007;73:210-4. (Pubitemid 351396696)
8. Kashiwabara M, Miyashita M, Nomura T, et al. Surgical trauma-induced adrenal insufficiency is associated with postoperative inflammatory responses. J Nippon Med Sch 2007;74:274-83. (Pubitemid 47311974)
9. Meduri GU, Yates CR. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci 2004;1024:24-53. (Pubitemid 38879592)
10. Hew M, Bhavsar P, Torrego A, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006;174:134-41. (Pubitemid 44015386)
11. Pariante CM, Pearce BD, Pisell TL, et al. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999;140:4359-66. (Pubitemid 30647135)
12. Meduri GU, Muthiah MP, Carratu P, et al. Nuclear factor-kappaB-and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005;12:321-38.
13. Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 2006;1069:1-9. (Pubitemid 43989846)
14. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003;31:141-5. (Pubitemid 36151163)
15. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
16. Finfer S. Corticosteroids in septic shock. N Engl J Med 2008;358:188-90.
17. Daley MR. Corticosteroids for septic shock. N Engl J Med 2008;358:2068; author reply 2070-1.
18. Singh G, Sen N. Does low dose hydrocortisone reduce mortality in septic shock? Natl Med J India 2008;21:128-9.
19. Cooper MS. Is hydrocortisone an effective treatment for septic shock? Nat Clin Pract Endocrinol Metab 2008;4:368-9.
20. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.
21. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997;42:27-31. (Pubitemid 27045048)
22. Rivers EP, Gaspari M, Saad GA, et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001;119:889-96. (Pubitemid 32197664)
23. Offner PJ, Moore EE, Ciesla D. The adrenal response after severe trauma. Am J Surg 2002;184:649-53; discussion 653-4.
24. Gannon TA, Britt RC, Weireter LJ, et al. Adrenal insufficiency in the critically III trauma population. Am Surg 2006;72:373-6. (Pubitemid 46940730)
25. Rushing GD, Britt RC, Collins JN, et al. Adrenal insufficiency in hemorrhagic shock. Am Surg 2006;72:552-4. (Pubitemid 46952762)
26. De Jong MF, Beishuizen A, Spijkstra JJ, et al. Predicting a low cortisol response to adrenocorticotrophic hormone in the critically ill: a retrospective cohort study. Crit Care 2007;11:R61.
27. Hoen S, Asehnoune K, Brailly-Tabard S, et al. Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock. Anesthesiology 2002;97:807-13.
28. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45. (Pubitemid 30112218)
29. Drucker D, Shandling M. Variable adrenocortical function in acute medical illness. Crit Care Med 1985;13:477-9. (Pubitemid 15063833)
30. Drucker D, McLaughlin J. Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986;14:789-91. (Pubitemid 16003105)
31. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-96. (Pubitemid 35366095)
32. Marik P, Zaloga G. Prognostic value of cortisol response in septic shock. JAMA 2000;284:308-9; author reply 309.
33. Warner KJ, Cuschieri J, Jurkovich GJ, Bulger EM. Single-dose etomidate for rapid sequence intubation may impact outcome after severe injury. J Trauma 2009;67:45.
34. Bernard F, Outtrim J, Menon DK, Matta BF. Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications. Br J Anaesth 2006;96:72-6. (Pubitemid 43124535)
35. Dimopoulou I, Tsagarakis S, Kouyialis AT, et al. Hypothalamic-pituitary- adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med 2004;32:404-8. (Pubitemid 38234118)
36. Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine (Phila Pa 1976) 2006;31:E250-3.
37. Molloy S, Price M, Casey AT. Questionnaire survey of the views of the delegates at the European Cervical Spine Research Society meeting on the administration of methylprednisolone for acute traumatic spinal cord injury. Spine (Phila Pa 1976) 2001;26:E562-4.
38. McCutcheon EP, Selassie AW, Gu JK, Pickelsimer EE. Acute traumatic spinal cord injury, 1993-2000 population-based assessment of methylprednisolone administration and hospitalization. J Trauma 2004;56:1076-83.
39. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
40. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11. (Pubitemid 20152525)
41. Rozet I. Methylprednisolone in acute spinal cord injury: is there any other ethical choice? J Neurosurg Anesthesiol 2008;20:137-9.
42. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 2002;50:S63-72.
43. Buchman TG, Stein PK, Goldstein B. Heart rate variability in critical illness and critical care. Curr Opin Crit Care 2002;8:311-5.
44. Buchman TG. Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care 2004;10: 378-82. (Pubitemid 39313508)
45. Morris JA Jr, Norris PR, Waitman LR, et al. Adrenal insufficiency, heart rate variability, and complex biologic systems: a study of 1,871 critically ill trauma patients. JAm Coll Surg 2007; 204:885-92; discussion 892-3.
46. Morris JA Jr, Norris PR. Role of reduced heart rate volatility in predicting death in trauma patients. Adv Surg 2005;39:77-96. (Pubitemid 41737956)
47. Dorin RI, Pai HK, Ho JT, et al. Validation of a simple method of estimating plasma free cortisol: role of cortisol binding to albumin. Clin Biochem 2009;42:64-71.
48. Billeter A, Turina M, Seifert B, et al. Early serum pro-calcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg 2009;33:558-66.